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556 Abstracts August 2013artery (IAA) perfusion without dissection or rupture. We propose that arbi-
trarily defaulting to 10-12 mm endoconduit is unnecessary. Rather, we
suggest a dynamic approach in which operators select endoconduit size
by adding 2.7 mm to OD. This may result in the use of endoconduits
< 10 mm (Table). Furthermore, recent data show that iliac dissection
during EVAR may occur in as many as 38% of patients. This surprisingly
high incidence suggests that innovative approaches to circumnavigate
complicated iliac anatomy using endoconduits may be underutilized.
Custom-Made Fenestrated Stent Graft for Infrarenal Aortic Aneurysm
Repair with Coexistent Horseshoe Kidney
Wai-Ki Yiu, MBBS, PhD, FRCS, Yiu-Che Chan, Albert C. Ting, Stephen
W. K. Cheng. Department of Surgery, The University of Hong Kong,
Hong Kong, Hong Kong
Horseshoe kidney may cause technical and access problems during
open aortic aneurysm repair, and standard endovascular repair procedures
risk renal ischaemia due to the accessory renal arteries coverage. We report
a patient with a 5.4 cm infrarenal aortic aneurysm and horseshoe kidney,
with a large accessory renal artery supplying most of the right moiety and
isthmus of horseshoe kidney arising from the sac. In order to prevent renal
malperfusion, endovascular repair using a custom made bifurcated stent
graft (26 mm  112 mm) with a single fenestration intended for the acces-
sory renal artery (Cook Zenith, Bloomington, Ind) was performed. An
Atrium balloon-expandable covered stent 6  22 mm (Atrium Medical
Corporation, NH) was deployed through this fenestration into the accessary
renal artery. The procedure was successful with renal preservation and
successful exclusion of the aneurysm at 3-months’ CT scan. To our knowl-
edge, this is one of the ﬁrst reports in the published literature of this
technique.
The “Periscope” Technique Successfully Lengthens the Distal Landing
Zone During TEVAR
Vinit Varu, MD, Venita Chandra, MD, Michael D. Dake, MD, Jason T.
Lee, MD. Stanford University, Stanford, Calif
Objectives: We describe our early experience with the “periscope”
technique to extend the distal landing zone and successfully treat distal
thoracic pathology in patients with inadequate distal seal zones near the
mesenteric vessels.
Methods: Four consecutive patients with planned endovascular repair
of complex TAA extending near mesenteric and renal arteries were
reviewed. In the periscope conﬁguration, which is similar to an upside-
down snorkel/chimney approach, parallel stent grafts adjacent to the
TEVAR device were placed into the mesenteric and renal vessels from the
contralateral femoral approach.Results: Six periscope grafts (4 SMA, 2 in solitary renal arteries) were
utilized in four patients (mean age, 72 years). Mean aneurysm diameter was
69.5 mm (range, 59-85 mm), and the “periscope” conﬁguration improved
the distal seal zone from a diameter of 45 mm and length of 0 mm to a more
appropriate landing zone of 33 mm diameter and 28 mm length. Technical
success was 100% and all patients are alive at latest followup (mean, 15.1
months; range, 9-23). The only morbidity was reoperation for femoral
access occlusion. Postoperative follow-up imaging revealed all six periscopes
to be patent. One small type Ib and one type II endoleak have been
observed without aneurysm sac enlargement. All aneurysms have regressed
with mean sac change of -4.7 mm.
Conclusions: In select high-risk patients opting for an all-endovascu-
lar approach of distal thoracic pathology, the “periscope” technique is
successful in extending the landing zone into juxtamesenteric and juxtarenal
anatomies to provide successful aneurysm exclusion. Long-term follow-up is
obviously necessary to assess for continued protection from aneurysm
rupture, but at this point it appears to be safe and effective until fenes-
trated/branched grafts become more widely available.
Occlusive and Aneurysmal Disease: A Novel Role for the Endologix
Abdominal Endograft
Omid Jazaeri, MD,1 Jeniann Yi, MD,2 Paul Rochon, MD,2 Rajan
Gupta, MD,2 Joshua Greenberg, MD,2 David Kuwayama, MD,2 Mark
Nehler, MD2. 1Surgery, University of Colorado School of Medicine,
Aurora, Colo; 2University of Colorado School of Medicine, Aurora, Colo
Objectives: Coexisting aorto-iliac occlusive disease is not
uncommon in patients undergoing treatment for aorto-iliac aneurysms.
We have preferentially used the Endologix abdominal endograft in these
patients given the graft's unique properties including a bifurcation-sparing
nature and low proﬁle delivery. We aimed this study at reviewing our
single-center experience in this homogenous cohort of patients affected
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abdominal endograft.
Methods: A retrospective review of all endovascular aorto-iliac aneu-
rysms repaired with an Endologix device was perfomed at a single institution
between January 2008 and April 2013. This revealed 51 patients who were
treated with the Endologix device for aorto-iliac aneurysms who had coex-
isting aortoiliac occlusive disease. Patient demographics, procedural details,
and clinical follow-up were reviewed.
Results: All nine (100%) of the patients had claudication and three
(33%) had CLI. One patient presented with an aortic rupture and the
remaining eight patients were elective. Successful deployment of the endo-
vascular device was achieved in all nine (100%) patients. There was no 30-
day mortality or reintervention within 1 year. Of the nine patients, three
(33%) had complete iliac occlusions which were all crossed utilizing an
Outback re-entry device. The remaining six (66%) patients all had iliac
stenoses and two (22%) also had aortic stenoses. Preprocedural and postpro-
cedural ABIs were available in 8 of 9 patients. Mean bilateral preprocedure
ABI was 0.70 which increased to 0.86 postprocedure.
Conclusions: Signiﬁcant coexisting arterial disease may be encoun-
tered in patients with aortic or iliac aneurysms. Identiﬁcation of coexisting
arterial diseases is essential to help tailor treatment for coexisting occlusive
and aneurysm disease. The Endologix abdominal endograft has properties
that perform well in this patient population in our single-center review.
Risk Factors for 30 Day Hospital Readmission in Patients Undergoing
Treatment for Peripheral Artery Disease
Sukgu M. Han, MD, Bian Wu, MD, Charles M. Eichler, MD, Linda M.
Reilly, MD, Shant M. Vartanian, MD, Michael S. Conte, MD, Jade S.
Hiramoto, MD. Division of Vascular and Endovascular Surgery, University
of California, San Francisco, San Francisco, Calif
Objectives: Early hospital readmission among vascular surgery
patients has become a focus for the restructuring of Medicare's reimburse-
ment system; however, risk factors for these readmissions remain poorly
characterized. We aim to identify factors associated with 30 day readmission
after peripheral artery interventions.
Methods: Retrospective analysis of 175 consecutive patients dis-
charged between 1/1/2011-7/31/2012 who underwent treatment for
lower extremity peripheral artery disease, which included open and endovas-
cular aortoiliac procedures, infrainguinal revascularizations, and amputa-
tions. Data on demographics, comorbidities, length of stay, type of
operation performed, and functional status were acquired from the elec-
tronic medical record.Table. Patient characteristics
Nonreadmission
group
Readmission
group P value
Total 133 37
Age 69 0 6 11.4 68.7 6 11.4 .87
Male gender 67% 54% .15
Race .33
White 93 (67%) 23 (62%)
Black 12 (9%) 5 (14%)
Hispanic 15 (11%) 2 (5%)
Asian 10 (7%) 6 (16%)
Others 8 (6%) 1 (3%)
Diabetes mellitus 69 (50%) 14 (38%) .18
Hypertension 113 (83%) 33 (89%) .33
Coronary artery disease 54 (39%) 14 (37%) .86
Congestive heart failure 17 (12%) 4 (11%) .8
Hyperlipidemia 78 (57%) 18 (49%) .39
Stroke 19 (14%) 4 (11%) .64
Chronic kidney disease 22 (16%) 12 (33%) .02
End stage renal disease 13 (9%) 6 (16%) .24
Chronic pulmonary obstructive
disease
24 (17%) 7 (19%) .83
Smoking 93 (67%) 21 (57%) .23
Venous thromboembolism 8 (6%) 2 (5%) .93
Atrial ﬁbrillation 15 (11%) 5 (14%) .65
Length of stay, days 7.74 7.65 .65
Urgency of operation 24 (17%) 13 (35%) .02
Functional status at discharge .08
Ambulatory 120 (87%) 28 (76%)
Wheelchair-bound 14 (11%) 5 (13%)
Bedbound 4 (3%) 4 (11%)Results: 37/175 (21%) patients were readmitted within 30 days of
discharge; 7/37 (19%) readmissions were planned. There were no signiﬁ-
cant differences in demographic characteristics, comorbid conditions, length
of hospital stay, or discharge functional status between the readmitted and
nonreadmitted groups (Table). Readmitted patients were more likely to
have undergone an urgent operation (P ¼ .02). In a multivariate logistic
regression model, urgency of operation (OR, 3.42; 95% CI, 1.35-8.67)
and either chronic kidney disease or end stage renal disease (OR, 3.71;
95% CI, 1.39-9.91) were signiﬁcantly associated with increased risk of 30
day readmission. Diabetes mellitus was associated with a lower risk of read-
mission (OR, 0.32; 95% CI, 0.12-0.83). The most common reasons for
readmission were infection, either of the surgical site or index limb (18/
37 ¼ 49%) followed by persistent nonhealing wounds or rest pain in the
index limb (11/37 ¼ 30%). Graft failure requiring reintervention accounted
for 3/37(8%) of readmissions.
Conclusions: Thirty-day readmission is frequent after peripheral artery
interventions, with themajority of these related to the index limb.Urgent oper-
ative intervention and compromised renal function appear to be risk factors for
early hospital readmission.
Lower Extremity Autogenous Vein Bypass for Critical Limb Ischemia
Is Not Adversely Affected by a Failed Endovascular Procedure
Vincent J. Santo III, MD, Phong Dargon, MD, Amir Azarbal, MD, Timothy
Liem, MD, Erica Mitchell, MD Gregory Landry, MD, Gregory
Moneta, MD. Surgery, Oregon Health and Science University, Portland, Ore
Objectives: It has been reported a failed endovascular intervention
adversely affects results of lower extremity bypass (LEB). We reviewed rates
of prior endovascular intervention in patients undergoing LEB with autolo-
gous vein for critical limb ischemia (CLI) to determine effects on graft
patency, limb salvage and amputation free survival (AFS).
Methods: Review of consecutive autologous vein LEBs performed for
CLI between 2005 and 2012 at a tertiary care academic medical center.
Results: Overall there were 311 autologous vein LEBs performed for
CLI; 70% for tissue loss. TASC D or C lesions were present in 61% and
25%, respectively. The greater saphenous vein was used as a conduit in 83%
and the distal target was infra-popliteal in 60%. 30-day mortality was 3.5%.
One and 5-year primary patency was 61% and 45%.One and 5-year secondary
patency was 88% and 65%, with 23% requiring an intervention to maintain
patency. Five-year limb salvage was 90% and 5-year AFS was 49%.
Sixty patients (19%) had undergone a prior ipsilateral endovascular
intervention (PEI) and 251 were felt to be unsuitable for an endovascular
intervention (NPEI). PEI and NPEI patients had similar demographics
and prevalence of atherosclerotic risk factors. One-year primary and
secondary patency were 61% and 87% for PEI patients and 60% and 89%
for NPEI patients (P ¼ NS). Three-year secondary patency was 76% for
PEI and 68% for NPEI (P ¼ NS). Three-year limb salvage was 94% for
PEI vs 89% for NPEI (P ¼ NS). Three-year AFS was 53.6% for PEI vs
59.1% for NPEI (P ¼ NS).
Conclusions: Overall operative mortality, patency rates and limb
salvage for autologous vein LEB in CLI patients continue to be excellent
in the endovascular era and are not necessarily affected by a prior failed ipsi-
lateral endovascular procedure. Long-term survival remains poor in CLI
patients requiring LEB.
Endovascular Therapy Is Effective Treatment for Focal Stenoses in
Failing Infrapopliteal Grafts
Gregory G. Westin, MAS, Ehrin J. Armstrong, MD, MSc, MAS, Satinder
Singh, MD, Haseeb Saeed, MD, William C. Pevec, MD, John R.
Laird, MD, David L. Dawson, MD. University of California, Davis,
Sacramento, Calif
Objectives: To evaluate the efﬁcacy of endovascular therapy in failing
infrapopliteal bypass grafts to maintain patency and preserve limbs.
Methods: This is a retrospective review of endovascular procedures to
preserve graft patency. Data were derived from a registry of catheter-based
procedures for peripheral artery disease and review of records and angio-
graphic images. Of 1554 arteriograms performed from 2006 to 2012, there
were 44 interventions in 35 patients for failing bypass vein grafts to infrapo-
pliteal target vessels. The ﬁrst intervention for each patient was used in this
analysis. Duplex ultrasound scanning (DUS) was routinely used within 30
days and at 3-6 month intervals for graft surveillance.
Results: Interventions were performed for recurrent symptoms of
critical limb ischemia in 43% and for stenoses identiﬁed by DUS in 57%.
Procedural techniques included cutting balloon angioplasty (74%), conven-
tional balloon angioplasty (14%), stent placement (9%), and laser atherec-
tomy and thrombectomy (3%). Procedural success was achieved in 34 of
35 cases (97%). There were no procedure-related complications,
